Trial Profile
Trial of Roflumilast in Asthma Management (TRIM)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2022
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms TRIM
- 11 Aug 2021 Status changed from recruiting to completed.
- 16 Jul 2020 Status changed from suspended to recruiting.
- 04 May 2020 Planned End Date changed from 1 Sep 2020 to 1 Sep 2021.